Literature DB >> 12695124

CD4+CD25+ T cells as key regulators of immune responses.

Bertrand Dubois1, Ludivine Chapat, Anne Goubier, Dominique Kaiserlian.   

Abstract

Discredited a few years ago, active suppression is now commonly considered as a key mechanism avoiding auto-reactivity and development of potentially harmful immune responses, and in some circumstances, as an obstacle to successful vaccination. A large quantity of literature identifies naturally occurring CD4+CD25+ T cells as key suppressor cells involved in the control of many pathophysiological diseases. Manipulation of these cells and control of their function offers new perspectives for the treatment of auto-immune and inflammatory diseases and enhancement of vaccine efficacy. Such clinical interventions require a better understanding of the conditions of expansion/activation of CD4+CD25+ T cells and deciphering of their mechanism of suppression, which remains incomplete and sometimes controversial.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695124

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  3 in total

1.  Depletion of regulatory T cells in a hapten-induced inflammation model results in prolonged and increased inflammation driven by T cells.

Authors:  A D Christensen; S Skov; P H Kvist; C Haase
Journal:  Clin Exp Immunol       Date:  2015-03       Impact factor: 4.330

2.  Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy.

Authors:  Pierpaolo Correale; Maria Saveria Rotundo; Maria Teresa Del Vecchio; Cinzia Remondo; Cristina Migali; Chiara Ginanneschi; Kwong Y Tsang; Antonella Licchetta; Susanna Mannucci; Lucia Loiacono; Pierfrancesco Tassone; Guido Francini; Pierosandro Tagliaferri
Journal:  J Immunother       Date:  2010-05       Impact factor: 4.456

Review 3.  Herpes simplex virus type 2 vaccines: new ground for optimism?

Authors:  L Aurelian
Journal:  Clin Diagn Lab Immunol       Date:  2004-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.